Live Breaking News & Updates on Ioana Piscociu|Page 3

Stay updated with breaking news from Ioana piscociu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Capital Markets Day 2023 - Ipsen Outlines Next Phase Of Growth & Transformation And Provides New Mid-Term Outlook

Capital Markets Day 2023 - Ipsen Outlines Next Phase Of Growth & Transformation And Provides New Mid-Term Outlook
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , France General , United States , Amy Wolf , Christelle Huguet , Ioana Piscociu , Ipsen Euronext , David Loew , Nicolas Bogler , Stewart Campbell , Mari Scheiffele , Bartek Bednarz , Aymeric Le Chatelier , Capital Markets Day , Chief Executive Officer , Specialty Care , Generation Ipsen , Chief Financial Officer , Global Product , Portfolio Strategy , North America , Rare Disease , Sponsored Leveli American Depositary Receipt , French Autorite , Des Marche ,

Ipsen Pharma: Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook

Ipsen Pharma: Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , France General , United States , Stefan Klotter , Nicolas Bogler , Stewart Campbell , Ioana Piscociu , David Loew , Christelle Huguet , Bartek Bednarz , Ipsen Euronext , Amy Wolf , Mari Scheiffele , Aymeric Le Chatelier , Capital Markets Day , Chief Executive Officer , Specialty Care , Generation Ipsen , Chief Executive , Chief Financial , Global Product , Portfolio Strategy , Rare Disease , French Autorit , Des March ,

Ipsen Pharma: Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC

Ipsen Pharma: Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France General , United Kingdom , United States , Ioana Piscociu , Nicolas Bogler , Stefan Klotter , Kumagit Heathcote , Anna Gibbins , Ipsen Euronext , Amy Wolf , Christelle Huguet , Pascal Prigent , Stephanie Boyer , European Medicines Agency , Uncertainties Of The Company , Head Of Research Development , Regulatory Agency , Committee For Medicinal Products Human Use , Exchange Commission , Drug Administration , New Drug Application , Medicines Agency , Marketing Authorization Application , Medicinal Products , Human Use , United Kingdom Medicines ,

GENFIT: Results from Ipsen's ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13.11.23

GENFIT: Results from Ipsen's ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13.11.23
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United Kingdom , France General , United States , Ipsen Euronext , Ioana Piscociu , Jean Christophe Marcoux , Christelle Huguet , Stephanie Boyer , Anna Gibbins , Mo Christie , Christopher Bowlus , Amy Wolf , Nicolas Bogler , Global Head Of Franchise Communications , University Of California Davis , Head Of Patient Services , Corporate Affairs , Exchange Commission , Uncertainties Of The Company , Head Of Corporate Brand Strategy Communications Tel , Head Of Research , Primary Biliary , American Association , Liver Diseases , New England Journal , Primary Biliary Cholangitis ,

Medison Pharma; Ipsen: Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Medison Pharma; Ipsen: Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , France General , United Kingdom , Intrahepatic Cholestasis , Gastroenterol Hepatol , Gil Gurfinkel , Ioana Piscociu , Dara Willis , Jennifer Moore , Medison Pharma , Walter Perez , Nicolas Bogler , Amy Wolf , Ipsen Euronext , Stewart Campbell , Inbal Chen , Binita Kamath , Division Head , Global Corporate Communications , Health Canada , Resource Network , Gage Communications , Head Of Corporate Brand Strategy Communications , Corporate Communications , Progressive Familial Intrahepatic Cholestasis , Executive Vice President ,